The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 31, 2015

Filed:

Oct. 14, 2011
Applicants:

Eric Richard Sjoberg, San Diego, CA (US);

Gary Lee, West Windsor, NJ (US);

Inventors:

Eric Richard Sjoberg, San Diego, CA (US);

Gary Lee, West Windsor, NJ (US);

Assignee:

Amicus Therapeutics, Inc., Cranbury, NJ (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/48 (2006.01); A61K 38/55 (2006.01); C07C 231/06 (2006.01); C07K 5/103 (2006.01); C07K 7/06 (2006.01); C12Q 1/37 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07C 231/06 (2013.01); C07K 5/1013 (2013.01); C07K 7/06 (2013.01); C12Q 1/37 (2013.01); A61K 38/00 (2013.01); G01N 2333/8125 (2013.01); G01N 2333/966 (2013.01); G01N 2500/02 (2013.01);
Abstract

Pharmacological chaperone compounds and methods for the treatment of an individual having, or at risk of having, a disease condition associated with alpha-1-antitrypsin by using said compounds are disclosed. In particular, such methods are useful for the treatment or prevention of lung disorders associated with alpha-1-antitrypsin deficiency as well as liver disorders associated with an excess of alpha-1-antitrypsin. Suitable pharmacological chaperones include peptides and low-molecular weight compounds. Also provided is an assay for determining whether a test compound modulates alpha-1-antitrypsin activity.


Find Patent Forward Citations

Loading…